By Scott Wooldridge Life-science companies had another good quarter in Minnesota, and although the 3Q numbers are under the record-breaking investments for 2014, a large number of investments in new companies suggests continued growth. The LifeScience Alley 3Q investment report, from the Minneapolis-based trade association, finds that health technology firms raised more than $72.6 million […]
In this episode of DeviceTalks, we catch up with LifeScience Alley CEO Shaye Mandle about doing business in Minnesota’s world class medical device cluster. We delve into why the medical device and life sciences community clustered in the Twin Cities, what new trends in funding, M&A and technology are developing in the area and, of […]
Investment in Minnesota medical technology companies was strong again in the 2nd quarter, Minneapolis-based trade group LifeScience Alley said this week, with mHealth drawing particular attention. Total investment in the North Star State’s medtech sector was $116.4 million for the quarter, the 2nd-highest Q2 total the last 6 years. In all, 39 Minnesota medical device companies raised money, with seed and early-stage […]
Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to outsource some of the research and development work – and in the process, create a leaner, more flexible company.
Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis.
The panel, "Financing Opportunities in Today’s Marketplace," discussed venture capital, IPOs, strategic investors and the important role played by a board of directors play.
April 17, 2015 by Scott Wooldridge
LifeScience Alley, the Minneapolis-based trade association of medical device and life science companies, has chosen a new board chair and made other changes to its board of directors.
Medtronic CEO Omar Ishrak speaks with Lifescience Alley CEO Shaye Mandle at LSA2014.